Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Director, Life Sciences Institute, University of Michigan
Executive Partner, Sofinnova Ventures
Partner at New Enterprise Associates
The San Diego Biotechnology Network has organized a presentation by Dan Shoemaker, the chief technology officer at Fate Therapeutics, and Stephen Chang, the chief scientific officer of Stemgent. They will give a short talk on the industrialization of advanced technology for drug discovery and development based on induced pluripotent stem cells. More information and online registration is here.